GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Omeros Corporation (OMER) [hlAlert]

Rating:
Buy OMER
up 125.78 %

Omeros (OMER) rated Buy by Deutsche Securities

Posted on: Tuesday,  Nov 17, 2009  8:25 AM ET by Deutsche Securities

Deutsche Securities rated Buy Omeros Corporation (NASDAQ: OMER) on 11/17/2009, when the stock price was $6.98. Since
then, Omeros Corporation has gained 125.79% as of 01/26/2016's recent price of $15.76.
If you would have followed this Deutsche Securities's recommendation on OMER, you would have gained 125.78% of your investment in 2261 days.

Omeros Corporation is a clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company?s clinically advanced product candidates are derived from its PharmacoSurgerytm platform designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Its PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.

Deutsche Bank's award-winning Research team manages a range of functions from asset allocation, through economic forecasting across a broad range of industry sectors including cement and construction, chemicals, electronics, energy, engineering, machinery, media, software, tobacco, retailing and utilities, and oil and gas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/17/2009 8:25 AM Buy
None
6.98
as of 12/31/2009
1 Week down  -2.77 %
1 Month up  2.79 %
3 Months down  -0.28 %
1 YTD down  -0.28 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy